PP
ATNM icon

Patten & Patten’s Actinium Pharmaceuticals ATNM Stock Holding History

Patten & Patten’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,033
Closed -$359K – 213
2014
Q4 		$359K Sell
2,033
-84
-4% -$15.9K 0.05% 167
2014
Q3 		$425K Buy
+2,117
New +$420K 0.07% 160

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Patten & Patten's ATNM Position: Q1 2015 in Review

Patten & Patten sold out of Actinium Pharmaceuticals (ATNM) in Q1 2015, closing a stake of 2,033 shares — an estimated $359K sold.

Patten & Patten first reported a position in ATNM in Q3 2014 and held it in 2 quarters. The position peaked at $425K in Q3 2014. 42 funds tracked by Wall St. Rank hold ATNM as of Q1 2015.

  • Patten & Patten reported no remaining Actinium Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Patten & Patten sold 2,033 Actinium Pharmaceuticals shares in Q1 2015, an estimated $359K.
  • Patten & Patten first reported a position in Actinium Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • Patten & Patten's Actinium Pharmaceuticals position peaked at $425K in Q3 2014.
  • 42 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2015.

Based on Patten & Patten's 13F filing for Q1 2015, filed 16 Apr 2015.